I've spent years advocating for Project Facilitate to be FDA-wide, not only oncology, but it seems that's not in the cards, which is a real shame.) You can join the webinar at https://t.co/QF0Xg4rtHt at noon ET or you can catch the archived recording (I think).
Alison Bateman-House
19m
I'm excited to be part of #FDA#Oncology Center of Excellence's webinar on Project Facilitate today! Project Facilitate is a fantastic service for those who need help with an Expanded Access (aka "compassionate use") request
Brendan Parent, JD, is visiting from NYU for his lecture, "Respecting and Learning from the Dead: Ethical Research Involving the Physiologically Maintained Deceased." Register here for lunch: https://t.co/IWs43GGLxm
Pharma CEOs should demand Prasad’s departure
FDA’s CBER director is endangering patients, damaging FDA, and destabilizing drug companies — and Moderna’s flu vaccine won’t be his last target.
Comment from @steveusdin1 https://t.co/nqH8dr2Gxf
A followup from @ZacharyBrennan on the fundamental breakdown going on at the FDA over the $MRNA decision. Regulatory chaos as the leadership at the FDA breaks with staff to enforce an anti-vaccine agenda is lethal for biotech. It's hard enough developing drugs without an anti-science political crusade interfering in the process.
https://t.co/q6Qm3IjiSv
CMS’ new MAHA ELEVATE innovation model has a fundamental flaw––no definition of what is a "medicine", opening the door for quackery https://t.co/oVSizL1fOp via @statnews